Investigational Site Number :1240007

Markham, Ontario L3P 1X3

0 studies enrolling now · 1 studies all time

What they study most

Neurodermatitis

Studies at this site

• Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2) — Completed